Novavax, Inc. (NASDAQ:NVAX) Q2 2025 Earnings Call Transcript August 6, 2025
Novavax, Inc. beats earnings expectations. Reported EPS is $0.601, expectations were $-0.19.
Operator: Good morning, and welcome to Novavax Second Quarter 2025 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Luis Senay, Vice President, Investor Relations. Please go ahead.
Luis Sanay: Good...
